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Abstract
Background: Flavonoids and other polyphenols play a protective role in liver diseases and possess a high
antioxidant capacity.
Objective: To compare and evaluate the antioxidant and hepatotoprotective activities of 4 deserts plants, Fagonia
indica Burm. f., Calotropis procera R.Br., Zygophylum hamiense Schweinf. and Salsola imbricata Forssk. in correlation
to their composition especially their phenolic content.
Methods: The influence of extracting solvent on total phenolic and flavonoidal contents was assessed
spectrophotometrically. The flavonoid and other polyphenolic components of the methanol extracts were analyzed
by RP-HPLC. DPPH radical scavenging potential of the different extracts was estimated. The hepatoprotective and
antioxidant activities of the extracts against CCl4-induced hepatotoxicity in mice were evaluated.
Results: The flavonol quercitrin and rosmarinic acid were major in the F. indica, C. procera and S. imbricata
samples, while rutin prevailed in that of Z. hamiense. The ethanolic and methanolic extracts showed noticeable DPPH
radical-scavenging activity as compared to ascorbic acid. Assessment of liver enzymes revealed that oral administration
of the extracts did not show any evidence of hepatotoxicity. Moreover, protection against CCl4-induced liver damage
was evident upon administration of three plants extracts namely, F. indica, C. procera and S. imbricata.
Conclusion: Overall, hepatotoxicity induced by CCl4 was effectively prevented by the three plants extracts through
scavenging of free radicals and by boosting the antioxidant capacity of the liver. The protective effect of the plants
could be attributed to their high quercitrin and rosmarinic acid contents.
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Background
Human beings are daily exposed to various compounds
that can cause serious diseases either per se or through
their metabolic activation to highly reactive substances
such as reactive oxygen species (ROS). Free radical in-
duced lipid peroxidation is regarded as one of the main
causes of cell membrane damage leading to various patho-
logical conditions [1, 2]. Liver disorders are considered
among the major world health problems [3]. Despite their
prevalence, morbidity and mortality rates, their current
medical management is still considered inadequate. Until
now, no therapy shows complete success in preventing
the disease progression [4]. Besides, the newly developed
drugs used in management of chronic liver diseases are
usually associated with various, and sometime intolerable,
side effects [5]. Consequently, medicinal plants, especially
those with traditional use, have always been considered as
a rich source of new effective drugs which could help in
ameliorating liver conditions.
Among plant metabolites, phenolics are reputed to
play a noticeable protective role against several health
disorders [6]. Phenolics possess various biological activ-
ities, for instance, antiulcer, anti-inflammatory [7], anti-
diabetic [8], antioxidant, cytotoxic and antitumor [9, 10].
Fagonia indica Burm. f. (Mushikka or white spine)
(Zygophyllaceae) is a widely distributed plant in the
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deserts of Asia and Africa. It has been reported as medi-
cinal herb in the scientific literature. In an earlier study,
the main author reported that the plant could be consid-
ered as safe and that it contained a variety of bioactive
flavonoids, sterols and triterpenoids; its alcoholic extract
was found to exhibit antitumor, antimicrobial and anal-
gesic activities [11]. Furthermore, the methanolic extract
of an Indian sample of the plant was proven to exert a
hepatoprotective effect in rats; however, the mechanism
of action has not yet been explored [12].
Calotropis procera R. Br. (Asclepiadaceae), known as
Giant milkweed and locally called Al-ashkhar [13], has
been used for treating various diseases like rheumatism,
filariasis and skin disorders [14] and its leaf to treat
jaundice [15]. The flowers extract have been used for
treating spleen, liver and abdomen diseases [16]. Add-
itionally, various extracts of its different parts showed
antibacterial and in-vitro and in-vivo antioxidant activ-
ities [17–20]. Earlier phytochemical investigation of C.
procera revealed the presence of cardenolides, flavo-
noids, steroids and saponins [21, 22]. The composition
of the volatiles, lipoids and flavonoids of its flowers were
previously investigated by the author [23].
Zygophyllum species (Family Zygophyllaceae) are used
as anthelmintic and for management of diabetes mellitus
[24, 25]. The aqueous extract of Zygophyllum album
showed in vivo antihyperglycemic, antioxidant and anti-
hyperlipidemic effects [26] as well in-vitro and in-vivo
antioxidant properties and phenolic contents of Zygo-
phyllum species were investigated [27–29]. Zygophyllum
hamiense Schweinf. spreads largely along the Arabian
Gulf area and grows on salt accumulated land. The dead
trees are commonly used as firewood and the sprouts as
camel food [30]. Yet, there are no available reports re-
garding either the composition or biological activities of
the Zygophyllum hamiense Schweinf.
Genus Salsola (Family Chenopodiaceae or Amarantha-
ceae) exhibited significant in-vitro antioxidant activities
[31–33]. Flavonoid and other phenolic compounds from
different species of Salsola have been reported. In addition,
triterpenes with significant antioxidant activity were isolated
[34, 35]. Salsola imbricata Forssk. (Arabic names: Harm),
is a shrub wild growing in Middle East deserts; it is
distributed throughout Central and Southwest Asia, North
Africa, and Mediterranean countries [36, 37]. Previous
phytochemical investigations and biological study of the
plant were limited. Two triterpenoidal saponin glycosides
were isolated and identified from the roots of the Egyptian
plant [38]. The phenolic profile of the alcoholic extract of
the plant was analyzed and its contraceptive effect in male
albino rats previously evaluated by the authors [39].
The selected plants are growing and existing in the de-
serts. The deserts plants almost contain variety of second-
ary metabolites like flavonoids and phenolic acids to
protect themselves from herbivores. Thus it was valuable
and interesting to perform a comparative study on some
selected desert plants from different genus, Fagonia indica
Burm. f., Calotropis procera R.Br., Zygophylum hamiense
Schweinf. and Salsola imbricata Forssk., and to correlate
their biological activities such antioxidant and hepatoto-
protective to their phenolic composition.
Methods
Chemicals and drugs
Methanol, ethanol, acetone and ethyl acetate were pur-
chased from Fisher Scientifics (UK) & Scharlam. Carbon
tetrachloride (CCl4), 2,2-diphenyl-1-picrylhydrazyl (DPPH),
sodium carboxymethylcellulose (CMC), Biochemical kits
for determination of glutathione peroxidase (GPx), super-
oxide dismutase (SOD), Catalase (CAT), Thiobarbituric acid
reactive substances (TBARS) were purchased from Sigma
Chemical Co. (St. Louis, MO, USA) and Folin-Ciocalteu
reagent was obtained from Merck (Darmstadt, Germany).
All other chemicals were of analytical grade.
Plants material
Whole plants of Fagonia indica Burm. f., Zygophylum
hamiense Schweinf., Salsola imbricata Forssk. and leaves of
Calotropis procera R. Br. were collected during September
2012 from Muhaisnah desert, Dubai, UAE. The samples
were kindly identified and authenticated by Prof. Hassnaa
Ahmed Hosny, Department of Botany, Faculty of Science,
Cairo University, Egypt. Voucher specimens were kept at
the Herbarium of the Pharmacognosy Department,
Faculty of Pharmacy, Cairo University. Samples, air-dried
in shade, were powdered and preserved for further study.
Experimental animals
Acute toxicity
The acute toxicity studies of both F. indica and S. imbricata
have been previously reported [11, 39]. Male albino mice
weighing 20–25 g (10 per group) were used to estimate
the acute toxicity of the other two plants viz., Z. hamiense
and C. procera. LD50 was estimated using 50 % death
within 72 h following oral administration of the extracts at
different doses (250, 500, 1000, 2500 and 5000 mg/kg).
The number of animals, which died during this interval,
was expressed as a percentile, and the LD50 determined by
probit test using a death percent versus doses’ log [40].
Treatment protocol
Eighty four healthy male albino mice of weights ranging from
30-35 g were used. Animals were kept under the same stand-
ard hygienic conditions (temperature 22.0 ± 2.0 °C, relative
humidity 50–60 %, with 12 h day/night lighting cycle), fed
with well-balanced normal diet and water supplied ad libi-
tum. They were left for a period of one week for accommo-
dation before performing the experiments. All animals’
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investigations were performed in accordance with the ethical
standards for the proper care and use of laboratory animals
and upon approval of the Research Ethical Committee of the
Dubai Pharmacy College, Dubai, United Arab Emirates.
Plants extracts
The four air-dried powdered plants materials (500 g, each)
were exhaustively extracted by cold maceration in 70 %
ethanol (3 L X 2). The solvents were evaporated under
reduced pressure at 50 °C. The residual weights for F.
indica, C. procera,, Z. hamiense and S. imbricata amounted
to 80.0, 44.5, 28.0 and 20.0 g, respectively. These dried
extractives were saved and used for biological evaluation.
Standardization of the plants extracts
Colorimetric monitoring of phenolic content in different
extracting solvents
Solvents of different polarities, namely: 70 % ethanol,
methanol, acetone and ethyl acetate were individually
used for extraction of the air-dried powdered plant ma-
terials (100 g, each).
The efficiency of the extracting solvent was monitored
by colorimetric estimation of total phenolic and fla-
vonoid contents using a spectrophotometer (UV-1700
Pharma Spec, Shimadzu, Japan). All experiments were
carried out in triplicate.
The total phenolic contents were determined by using
Folin-Ciocalteu reagent as described by Singleton and
Rossi [41] and modified by Oktay et al. [42]. Results
were expressed as mg/g gallic acid equivalent, calculated
on dry weight of plant material; serial dilutions of gallic
acid (10, 20, 30, 40, and 50 μg/mL) were used for estab-
lishment of the calibration curve. Aliquots (1 mL, each)
of tested samples and standard were, separately, added
to a volumetric flask containing 9 mL of water followed
by addition of 1 mL of Folin-Ciocalteu reagent and the
reaction mixture was carefully blended by vortex. After
5 min, 10 mL of 7 % sodium carbonate was added to the
mixture which was further incubated for 90 min, at
room temperature. Finally, the absorbance was deter-
mined at 750 nm against the reagent blank.
The total flavonoid content of the prepared extracts
was measured, spectrophotometrically, by the aluminum
chloride method, quercetin being used as standard, by
adopting the procedure described by Dewanto et al. [43].
The plants extracts (0.1 mL each) were added to 0.3 mL
distilled water followed by 5 % NaNO2 (0.03 mL) and
the reaction mixture was left for 5 min, at 25 °C. Alu-
minium chloride (0.03 mL, 10 %) was then added and
the mixture left for another 5 min, then treated with
0.2 mL of 1 mM NaOH, and finally diluted to 1 mL with
water and the absorbance of the yellow colour produced
read at 510 nm.
HPLC analysis of phenolics
The phenolic composition of the methanolic extract of S.
imbricata was previously analysed by the authors [39].
Methanolic extracts of the other three plants (F. indica, C.
procera and Z. hamiense) were investigated in aliquots of
1g each via RP-HPLC on a Hewlett Packard HPLC
System (HP 1050HPLCDADw/Data System). Analyses
were carried out at operating conditions suitable for
detection of either phenolic acids or flavonoids [44, 45].
For determination of phenolic acids, the apparatus was
equipped with an Alltima C18 column (particle size
5 mm, 150 × 4.6 mm) and Alltima C18 guard column
(5 mm) (Alltech, USA), the UV detector being set at
280 nm. Meanwhile, the separation of flavonoids was car-
ried out on a Hypersil-ODS C18 column (particle size 5 μ
m, 4.6 × 250 mm) and the UV detector was set at 330 nm.
All analyses were performed at 35∘C; gradient elution was
employed using acetonitrile-acetic acid mixtures as mobile
phase, at a flow rate of 1 mL/min, and the injected volume
was 10 μL for both standard and tested samples. Authen-
tic reference samples were prepared by diluting stock so-
lutions with methanol to afford a 50 μ g/mL final
concentration. Identification of individual components
was performed by comparing their retention times with
those of the available standards similarly analyzed. Quanti-
fication was based on peak area computation using the ex-
ternal standard method. All analyses were carried out in
triplicate. Samples were analyzed at 280 and 330 nm,
respectively.
Antioxidant activity
2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging
assay
The free radical-scavenging activities of the extracts of
the four plants (prepared in the following solvents: 70 %
ethanol, methanol, acetone, and ethyl acetate) were mea-
sured through the hydrogen donating or radical-
scavenging ability using the stable DPPH radical. The
assay was performed in a 96-well microtiter plate using
the modified previously described method [46]. Hundred
μl of each of the samples and the standard solutions
were mixed with 100 μl of 0.1 mM ethanolic DPPH
solution in the wells. The reaction mixtures were shaken
vigorously and incubated in dark for 30 min at 37 °C.
The absorbance was measured at 517 nm using UV–vis
microplate reader. The percentage inhibition (%) of the
DPPH radical by the samples was calculated using the
following formula:
% inhibition ¼ A0− A1− A2ð Þ½ =A0  100%
Where A0 is the absorbance of the control, A1 is the
absorbance in the presence of the sample and A2 is the
absorbance of the sample under identical conditions as
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A1 with ethanol instead of DPPH solution. Ascorbic acid
(AA) was used as a reference compound. IC50 values
were calculated. Samples were analyzed in triplicate.
Experimental design
The residues of the ethanolic extracts for the four plants
were suspended in 1 % CMC. The animals were randomly
assigned to 14 groups, of 6 animals each (n = 6). Table 1
describes the animal grouping with their corresponding
treatment.
The first group served as normal control and during the
experiment received vehicle only (1 % CMC). The second
group was given 1 % CMC solution for 14 days before
CCl4 intoxication and served as a hepatotoxicity control
group. For each plant, three groups were devoted; the first
was treated with the plant extract twice daily for 14 days
while the second and the third groups were given the
plant extract in two different doses for 14 days as shown
in Table 1. After the 14-days treatment period, hepatic in-
jury was induced by intraperitoneal injection of 1.0 ml/kg
of CCl4 and the mice were sacrificed six hours after the
last treatment.
Assay of liver enzyme
Blood samples were collected from the hearts with the
use of 5 ml sterile syringe individually for each mouse
and transferred into non-heparinized tubes immediately
and used later for the analyses of liver enzymes: alanine
aminotransferase (ALT), aspartate aminotransferase
(AST) and alkaline phosphatase (ALP).
Estimation of oxidative parameters
Liver samples were surgically removed from the mice
immediately and stored in -80° for further antioxidant
enzyme assay including activity of catalase, superoxide
dismutase, glutathione peroxidase and TBARS as per the
method described by Abu-Gharbieh et al. [47]. The
levels of total protein were determined in the serum of
experimental animals by using the Lowry method and
the bromocresol green method, respectively [48, 49].
Histopathological study
Liver samples were suspended in 10 % formaldehyde for
histological evaluation. These tissues were processed and
embedded in paraffin wax. Sections of 5 μm in thickness
were cut and stained with hematoxylin and eosin (H&E)
and Periodic acid-Schiff (PAS) stains.
Statically analysis
The results were reported as Mean ± Standard Deviation
(S.D) from three repeated determination. The data ob-
tained were statistically analyzed using One-way analysis
of variance ANOVA, followed by Dunnett’s multiple
comparison test (DMCT). P-value of < 0.05 was consid-
ered as statistically significant.
Results
Standardization of the plants extracts
Influence of extracting solvent on total phenolic and
flavonoid contents
Different solvents were used to select the most efficient, safe
and applicable solvent for phenolic compounds extraction as
shown in Table 2.
Spectrophotometric evaluation of the total phenolic con-
tent (expressed as mg gallic acid equivalent (mg GAE)/g
dry plant material) and flavonoid content (as quercetin g/
100 g dry plant material) in the extracts of F. indica, C. pro-
cera and Z. hamiense revealed variable efficiency. Ethanol
Table 1 Animals groups and corresponding treatment with vehicle, tested samples and carbon tetrachloride
Oral treatment Frequency i.p. CCl4 injection
Control Vehicle daily -
CCl4 control Vehicle daily 1.0ml/kg
F. indica extract 10 mg/kg Twice daily -
5mg/kg daily 1.0 ml/kg
10 mg/kg daily 1.0 ml/kg
Z. hamiense extract 500 mg/kg Twice daily -
250 mg/kg daily 1.0 ml/kg
500 mg/kg daily 1.0 ml/kg
C. procera extract 200 mg/kg Twice daily -
100 mg/kg daily 1.0 ml/kg
200 mg/kg daily 1.0 ml/kg
S. imbricata extract 500 mg/kg Twice daily -
250 mg/kg Daily 1.0 ml/kg
500 mg/kg Daily 1.0 ml/kg
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was found to be the best solvent for extracting the F. indica
sample with highest concentration of phenolics (4 mg
GAE/g dry plant wt.) and flavonoids (3 g quercetin (Q) %
w/dry plant wt.). Concerning C. procera, the highest fla-
vonoid content was detected when using acetone (0.9 g Q
% w/dry wt.), while both ethanol and acetone extracts
were found the richest in total phenolics (4 mg GAE/g dry
wt.). On the other hand, the maximum flavonoid amount
(1.48 %) was extracted with acetone in Z. hamiense, mean-
while ethyl acetate and ethanol appeared of close efficien-
cies for solubilisation of total phenolics (4 and 3.61 mg
GAE/g dry plant wt., respectively). Finally, among the
tested plants and including S. imbricata, the most
enriched sample in both total phenolics and flavonoids
was F. indica (4 mg GAE/g of plant dry wt. and 3 g % w/
dry wt., expressed as quercetin respectively).
RP-HPLC profiling of phenolics
RP-HPLC analysis and total phenolic and flavonoid con-
tents of S. imbricata were previously determined [39].
RP-HPLC analyses of the methanolic extracts of the
remaining three plants, F. indica, C. procera, and Z.
hamiense, allowed the identification and quantitation of
several phenolics. Total of 14 components were identified
at 280 nm in both C. procera and F. indica (corresponding
to 10.297 and 7.955 % of the total composition, respect-
ively) and 13 components in Z. hamiense (corresponding
to 19.52 %) as shown in Table 3. Among these, the identi-
fied phenolic acids were 10 in F. indica (representing
4.84 %), 9 in C. procera (6.274 %) and 8 in Z. hamiense
(11.35 %). Ellagic and non-phenolic benzoic acids (1.2 and
1.02 %) were the prevalent in F. indica while in C. procera,
benzoic and salicylic acids (1.59 and 1.53 %) were the
Table 2 Total Flavonoid and phenolic acid contents of the different extracts of Fagonia indica, Calotropis procera, Zygophyllum
hamiense and S.imbricata

















F. indica 0.22 3.00 0.32 0.10 3.91 4.00 2.1 0.75
C. procera 0.12 0.3 0.90 0.10 3.13 4.00 4.00 0.92
Z. hamiense 0.38 0.14 1.48 0.11 2.60 3.61 1.20 4.00
S. imbricataa 0.571 0.217 0.374 0.11 2.60 0.64 4.00 0.93
aResults previously reported [39]
Table 3 Phenolics identified by RP-HPLC analysis (at λ = 280 nm) of the methanolic extracts of Fagonia indica, Calotropis procera,
Zygophyllum hamiense and S.imbricata
Retention time Identified constituent Relative area %
F. indica C. procera Z. hamiense S. imbricataa
6.81 Pyrogallol 0.145 0.173 1.94 -
6.92 Gallic acid 0.05 0.27 2.02 0.145
8.235 Protocatechuic acid 0.12 0.504 0.97 0.068
8.444 Catechin - 0.38 1.81 0.461
8.593 Chlorogenic acid 0.46 0.12 2.31 0.377
8.950 Catechol 0.16 0.44 2.57 0.329
10.040 Caffeic acid 0.25 - 1.54 1.759
11.073 Vanillic acid 0.37 0.82 1.37 0.286
11.620 Ferulic acid 0.34 0.36 0.84 1.323
12.466 Salicylic acid 0.73 1.53 1.1 1.154
12.943 Ellagic acid 1.20 1.20 - -
13.127 Benzoic acid 1.02 1.59 1.51 2.306
13.789 Coumaric acid 0.51 0.52 1.2 4.251
14.980 Cinnamic acid 0.81 0.95 - 0.371
18.657 Chrysin 1.79 1.44 0.34 1.074
Total identified constituents 7.955 10.297 19.52 13.904
aResults previously reported [39]
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major. On the other hand, chlorogenic and gallic acids
were predominant in Z. hamiense (2.31 and 2.02 %). In
contrast, 9 phenolic acids (9.734 %) with prevalence of
coumaric acid (4.251 %) were detected in S. imbricata
[39]. On the other hand, by setting the detector at λ =
330 nm, 8 components were identified in both F. indica
and C. procera among which 7 were of flavonoidal nature
with major quercitrin (5.29 and 4.16 % respectively) while
5 components only were determined in Z. hamiense
among which 4 were of flavonoidal nature with major
rutin (10.71 %) while quercitrin was the minor (0.77 %) as
shown in Table 4. Alternatively, 7 flavonoidal components
with major quercitrin (12.692 %) were previously detected
in S. imbricata. Besides, rosmarinic acid was detected in
all samples under investigation with relatively appreciable
amounts (Table 4).
DPPH free radical scavenging activity
DPPH is a stable free radical and its noticeable purple
color shows absorption at 517 nm. Antioxidants scavenge
the free radical by donating a hydrogen atom and the
color of the DPPH assay solution becomes yellowish,
resulting in a decrease of the absorbance. DPPH free rad-
ical scavenging activity is considered as in vitro screening
for possible in vivo antioxidant potentialities.
The four plants were tested and the results are pre-
sented in Fig. 1. All extracts were found to be potent
DPPH free radical scavengers and the highest activity
Fig. 1 DPPH radical scavenging activity of several plants extracts
Table 4 Phenolics identified by RP-HPLC analysis (at λ = 330 nm) of the methanolic extracts of Fagonia indica, Calotropis procera,
Zygophyllum hamiense and S.imbricata
Retention time Identified constituent Relative area %
F. indica C. procera Z. hamiense S. imricataa
3.83 Quercetin 0.034 0.08 0.04 0.031
11.78 Rosmarinic acid 2.83 2.68 2.33 2.734
12.06 Hesperidin 1.21 2.22 - 1.854
12.44 Rutin - 1.72 10.71 2.101
13.267 Quercitrin 5.29 4.16 0.77 12.692
14.576 Naringenin 1.36 1.15 0.94 1.300
14.952 Hesperitin 1.41 - - 0.730
15.147 Kampferol 1.61 1.5 - -
16.167 Apigenin 1.00 0.21 - 0.474
Total identified constituents 14.744 13.72 14.79 21.916
aResults previously reported [39]
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among all investigated plants samples was observed for
the ethanolic and methanolic extracts as shown in Fig. 1.
Acute toxicity study
The acute toxicity study was essential to evaluate the
plants extracts safety and to determine the tested doses.
The LD50 of both F. indica and S. imbricata extracts
had been previously reported and they were found to be
safe up to 4 and 5 g/kg respectively [11, 39]. Z. hamiense
was found to be safe up to dose 5 g/kg while C. procera
leaves extract was safe up to 3 g/kg. No signs of mor-
bidity or behavioral changes in any of the treated groups
of animals during the period of observation. The safety
margin of the ethanolic extracts of the plants under inves-
tigation is highly encouraging the biological evaluation.
Effects on liver enzymes and histological findings
The plants extracts were given twice daily over two weeks
in order to evaluate any possible hepatotoxicity caused by
the plants extracts themselves. Moreover, this was useful
to evaluate the effect of the extracts on the antioxidant
enzyme system apart from the CCl4 challenge.
Treating the animals twice daily with the plants ex-
tracts alone over two weeks, did not cause any signifi-
cant elevation on both the ALT and AST as shown in
Table 5. On the other hand, significant reduction in ALP
levels was observed by administration of the ethanolic
extracts of the four plants. This indicates that no pos-
sible cholestasis occurred at the dose levels tested since
a rise in plasma ALP level is usually a characteristic
feature in cholestatic liver disease [50]. Moreover, histo-
logical assessment revealed that the hepatocytes main-
tained its architecture with normal glycogen storage.
This gave evidence that the four plants did not produce
any harmful on the hepatocytes as shown in Fig. 2a. Be-
side this, treating the animals with the plants extracts
did not show any significant enhancement of the anti-
oxidant enzyme system.
Results in Table 6, showed that CCl4 caused sharp and
significant elevation in liver enzymes, ALT and AST by
598 % and 204 % respectively compared to control group
(p < 0.01), while ALP was not significantly affected.
Histological data revealed a dense periportal and lobular
lymphocytic infiltrate with diffused pyknotic nuclei
within necrotic hepatocytes in periportal areas. Fig. 2b.
Pre-treating the mice with F. indica, C. procera and S.
imricata extracts at the highest and lowest doses for
14 days prior CCl4 administration showed significant re-
duction in serum levels of ALT, AST but not ALP en-
zymes in a dose response manner (p-value less than 0.05
and 0.01, respectively). Those findings are supported by
the histological features; hepatocytes renewal and regen-
eration with mild glycogen depletion were observed with
F. indica, C. procera and S. imbricata only as shown in
Figs. 2c, d and e. On the other hand, pretreating the ani-
mals with Z. hamiense extract at both doses showed sig-
nificant reduction in AST level (p < 0.01) though ALT
and ALP levels were not changed (p > 0.05). Further-
more, histological study showed centralized gross glyco-
gen depletion (Fig. 2f ).
Effects on antioxidant enzymes and TBARS contents
Hepatotoxicity induced by CCL4 is characterized by sup-
pression of the antioxidant defense system [51–53] and
increased lipid peroxidation [51].
Administration of CCl4 markedly depleted the antioxi-
dant enzymes (CAT, GSH-Px and SOD) in the mice livers
(Table 6). Nevertheless, CCl4 increased significantly (p <
0.01) the hepatic lipid peroxidation that is expressed by
high TBARS content. Whereas the administration of
plants extracts twice daily for two weeks did not result in
significant enhancement of the antioxidant enzymes nor
reduction in the TBARS content as shown in Table 5.
Pretreating the animals with the plants extracts at dif-
ferent doses opposed significantly the reduction in the
antioxidant enzymes and reduced markedly the TBARS
content induced by CCl4 except for Z. hamiense extract
that has no potential effects on the antioxidant enzymes
as well as the TBARS content.
Table 5 Evaluation of the hepatotoxic effect of the plant extracts on the biochemical parameters with twice daily oral
administration in mice
Control F. indica Z hamiense C. procera S. imbricata
ALT 290.1 ± 54.0 350.2 ± 113.6 155.3 ± 65.5 211.0 ± 35.8 253.3 ± 24.0
AST 850.0 ± 63.2 800.0 ± 235.8 520.3 ± 220.0 404.2 ± 37.2b 653.3 ± 78.8
ALP 180.0 ± 20.3 113.3 ± 16.7a 105.6 ± 15.4a 98.2 ± 9.3b 60.0 ± 23.1b
CAT kU/g protein 462.0 ± 21.1 461.6 ± 14.9 428.750 ± 10.3 413.950 ± 11.4 486.3 ± 18.0
GSH-Px U/g protein 1.3 ± 0.1 1.3 ± 0.05 1.3 ± 0.07 1.6 ± 0.06 1.31 ± 0.14
SOD μg/g protein 34.6 ± 2.9 35.5 ± 2.7 32.8 ± 1.1 35.5 ± 1.4 32.1 ± 1.4
TBARS (nmol/g prot.) 0.49 ± 0.02 0.39 ± .03 0.046 ± 0.03 0.038 ± 0.02 0.035 ± 0.4
aSignificant difference (p < 0.05) compared to control group; bSignificant difference (p < 0.01) compared to control group
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Discussion
Liver diseases are one of the major causes of morbidity
and mortality and affects people of all ages throughout
the world especially in the Arab countries. The drugs
that are currently available to treat this condition pose
serious drawbacks [5], which justifies the search for new
hepatoprotective agents. In this context, the use of plants
extracts and isolates therefrom with hepatoprotective
properties can provide beneficial means for prevention
and treatment of liver conditions.
Alanine aminotransferase (ALT), aspartate amino-
transferase (ASL) are present mostly in the hepatic and
biliary cells [54]. These enzymes are usually released
from the hepatocytes and leak into circulation causing
increase in their serum levels under hepatocellular injury
or inflammation of the biliary tract cells resulting pre-
dominantly in an elevation of the alkaline phosphatase
levels. On the other hand, elevation in ALP is usually in-
dicates a cholestatic liver diseases.
Chronic administration of the four plants extracts for
two weeks resulted in significant reduction in alkaline
phosphatase levels. This shows that no possible cholesta-
sis occurred at the dose levels tested since a rise in
plasma ALP level is usually a characteristic finding in
cholestatic liver diseases [50]. This was further confirmed
by the fact that there were no significant changes in ALT
and AST. Accordingly the plants extracts did not exhibit
any signs of hepatotoxicity on chronic administration.
In this study, we were focusing on the liver injury that
always accompanied by elevated levels of serum hepatic
enzymes that are indicative of cellular leakage [55]. The
hepatotoxic effects induced by CCl4 are related to its
active metabolite trichloromethyl radical, •CCl3, this is
manifested by marked elevation in the serum liver en-
zymes namely AST, ALT, ALP [52]. Antioxidant en-
zymes, particularly, CAT, GSH-Px and SOD play a vital
role in protecting cells against oxidative damage. Admin-
istration of CCl4 to the animals leads to induction of
hepatic oxidative stress that is characterized by signifi-
cant decrease in CAT, GSH-Px and SOD activities and
increased TBARS content in liver tissue [52].
It was found that phenolic, especially polyphenolic,
compounds such as flavonoids are very efficient scaven-
gers of free radicals [56] because of their molecular
structures, which include an aromatic ring with hydroxyl





Fig. 2 Histopathological findings of mice liver sections (PAS x400); (a) treated with 10 mg/kg F. indica twice daily showing excess glycogen
synthesis; (b) negative control group treated with CCl4 alone showing dense periportal and lobular lymphocytic infiltrate with pyknotic nuclei
within necrotic hepatocytes in periportal areas and some other cells show degenerative changes; (c) treated with 10mg/kg F. indica and CCl4
showing normal regenerating hepatocytes sometimes binucleated; (d) treated with 200mg/kg C. procera and CCl4 showing normal glycogen
storage, stimulates regeneration and renewal of hepatocytes; (e) treated with 500mg/kg S. imbricata and CCl4 showing slight glycogen depletion
and (f) treated with Z. hamiense Schweinf and CCl4 showing glycogen depletion in centrizonal area and more glycogen and ballooning
degeneration on peripheral zone
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Table 6 Evaluation of the protective effect of the plants extracts on the biochemical parameters of liver in CCl4-induced hepatic damage in mice
Control CCl4 control F. indica Z hamiense C. procera S. imbricata
5 mg/kg 10 mg/kg 250 mg/kg 500 mg/kg 100 mg/kg 200 mg/kg 250mg/kg 500mg/kg
ALT (U/L) 290.1 ± 54.0 1736.7 ± 161.2a 2166.7 ± 157.8b 1064.0 ± 264.9c 1416.7 ± 105.8 950.3 ± 84.4 1054.3 ± 117.5c 801.7 ± 76.0c 1135.0 ± 127.9c 476.7 ± 151.0c
AST(U/L) 850.0 ± 63.2 1736.7 ± 215.1a 1310.0 ± 181.5b 926.2 ± 258.6c 756.7 ± 128.6c 783.3 ± 80.1c 787.8 ± 69.6c 922.7 ± 65.4c 647.5 ± 62.8c 530.0 ± 120.8c
ALP(U/L) 180.0 ± 20.3 150.2 ± 55.7 125.0 ± 22.5 124.3 ± 17.4 106.7 ± 24.0 113.3 ± 29.1 51.8 ± 4.7 59.5 ± 6.1 c 110.0 ± 14.7 63.3 ± 8.8
CAT kU/g protein 462.0 ± 21.1 241.3 ± 11.4a 307.2 ± 9.2c 392.200 ± 9.4c 225.1 ± 10.5 259.1 ± 5.1 324.7 ± 25.8b 335.0 ± 25.0c 356.2 ± 24.1c 374.9 ± 10.7c
GSH-Px U/g protein 1.3 ± 0.1 0.85 ± 0.06a 1.1 ± 0.2 1.2 ± 0.2 0.72 ± 0.1 0.94 ± 0.2 1.4 ± 0.06 1.4 ± 0.06 0.91 ± 0.06 1.39 ± 0.19b
SOD μg/g protein 34.6 ± 2.9 22.0 ± 2.4a 26.7 ± 1.8 32.9 ± 1.6c 21.1 ± 1.7 23.6 ± 1.5 22.7 ± 1.2 31.5 ± 1.1b 24.8 ± 0.5 26.4 ± 1.3
TBARS (nmol/g prot.) 0.049 ± 0.02 0.54 ± 0.20a 0.12 ± 0.09c 0.085 ± 0.05c 0.42 ± 0.2 0.36 ± 0.4 0.14 ± 0.07c 0.06 ± 0.01c 0.11 ± 0.05c 0.071 ± 0.02c


















known that the 3',4'-ortho-dihydroxy group in the B-ring
and the 5-OH group in the A-ring with a 4-carbonyl
group are required for the high antioxidant activity of
flavonoids. In addition, the presence of the o-catechol
group (3',4' -OH) in the flavonoid-B ring is a deter-
minant for high antioxidant capacities in flavonoids
(Fig. 3), [57]. The flavonoid content of Fagonia indica
exceeded those of the other plants by 10 to 30 folds. The
phenolic content of Salsola imbricata extract was pre-
viously reported to be 0.571 % [39]; while Calotropis
procera extract showed high phenolic acids content. The
frequently used DPPH assay was applied as a first in
vitro approach to assess the free radical-scavenging ac-
tivity of the plants extracts prepared in the different sol-
vents. This evaluation revealed that the methanolic and
ethanolic extracts of the four plants exhibited the high-
est DPPH radical scavenger potential with activity com-
parable to those of ascorbic acid, a well-known
antioxidant. However, for safety and economic con-
siderations, the ethanol (70 %) was selected for further
biological study.
Dose selection for the subsequent biological study for
the three plants (Zygophyllum hamiense, Calotropis pro-
cera and Salsola imbricata) was based on their LD50
values (less than 1/10 of LD50). Moreover, the major in-
fluencing factors to select smaller doses for Fagonia
indica extract (5 and 10 mg/kg) was the extremely high
contents of flavonoid and phenolic acid compared to the
other plants extracts. Additionally, similar doses of
Fagonia indica were tested previously for its analgesic
effect [11].
The three plants, Fagonia indica, Calotropis procera
and Salsola imbricata possessed high antioxidant and
hepatoprotective activities. These effects may be attrib-
uted to the presence of high content of different groups
of phenolic compounds including flavonoids aglycone
and/or glycosides and phenolic acids especially querce-
trin glycoside and rosmarinic acid (Fig. 3) that have been
earlier reported to exhibit strong antioxidant and hepa-
toprotective effects [58, 59]. Moreover, hesperidin and
its aglycone hesperitin, apigenin and cinnamic acid that
exhibited strong antioxidant and hepatoprotective activ-
ities [60–64] were detected in all plants extracts except
Zygophyllum hamiense of which rutin was the pre-
dominant flavonoid (10.71 %). The presence of high rutin
concentration in Zygophyllum hamiense extract explains
its in vitro free radical scavenging activity and possibly
it’s in vivo effect on AST level. Anyway, the plant could
not be considered as hepatoprotective since ALT level,
that is thought to be more specific for hepatic injury
[54], was not significantly improved. Accordingly, the
lack of other flavonoids especially quercetrin that pre-
sents in the other three plants explains the weak in vivo
antioxidant and hepatoprotective activities of Zygophyllum
hamiense against CCl4 intoxication.
Interestingly, it was found that although S. imbricata
contains the lowest amount of phenolic contents, its effi-
cacy in reducing ALT level in CCL4 treated mice still
high. This can be explained by the presence of triterpen-
oid saponin. Two triterpenoidal saponin glycosides were
isolated and identified from the S. imbricata, namely,
salisomide and salisoflavan [38], and it is reported in
literature that saponins interact with and increase perme-
ability of the mucosal cells in the gut and enhance the ab-
sorption of various nutrient [65, 66]. Therefore, saponin
enhanced the absorption of phenolic compounds. Add-
itionally, saponins themselves possess antioxidant activity
that contributes to efficacy of the phenolic compounds to
protect against liver injury induced by CCL4 [67, 68].
Based on that, it was found that F. indica, C. procera
and S. imbricata possess hepatoprotective effects by pre-
venting the induction of oxidative stress and enhancing
the hepatic antioxidant defences involving CAT, GSH-PX
and SOD enzymes and were highly efficient in reducing
the TBARS content in liver tissue. Accordingly, the three
plants could be added to the growing list of medicinal
plants. Further clinical studies are needed to evaluate their
clinical significance.
Conclusion
In conclusion, this study evidences the efficiency of the
ethanolic extracts of F. indica, C. procera and S. imbricata
Quercitrin Rosmarinic acid
Fig. 3 Chemical structures of quercitrin and rosmarinic acid
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in preventing the CCl4-induced hepatotoxicity in mice
through scavenging of free radicals and by boosting the
antioxidant capacity of the liver. The bioactive antioxidant
principles detected in the extracts are probably respon-
sible for this hepatoprotective effect. Therefore the parent
plants could be considered as a potential source of safe
protective from liver diseases or for reduction of un-
desirable hepatotoxic side effects of some drugs.
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